Molinalogo

Measure

2022

2023

Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

63.79%

62.54%

64.90%

Annual Dental Visits (ADV) Total

54.47%

48.70%

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

39.58%

77.01%

46.74%

Appropriate Testing for Pharyngitis (CWP)

75.24%

76.25%

77.56%

Appropriate Treatment for Upper Respiratory Infection (URI)

89.70%

90.55%

93.08%

Asthma Medication Ratio (AMR) Total

60.73%

65.38%

69.41%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

55.36%

65.85%

66.19%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

67.64%

63.50%

68.61%

Breast Cancer Screening (BCS)

47.82%

48.27%

55.25%

Cervical Cancer Screening (CCS)

52.07%

52.80%

59.85%

Childhood Immunization Status (CIS) Combination #10

26.28%

21.17%

35.04%

Chlamydia Screening in Women (CHL) Total

56.38%

57.21%

61.07%

Controlling High Blood Pressure (CBP)

60.83%

60.34%

65.45%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

81.58%

82.30%

80.86%

Eye Exam for Patients With Diabetes (EED)

48.66%

45.50%

56.20%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

20.35%

28.52%

27.73%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

55.98%

53.45%

46.35%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

29.78%

29.80%

41.03%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

39.82%

39.42%

37.31%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

43.75%

44.38%

57.90%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

50.12%

48.18%

55.72%

Immunizations for Adolescents (IMA) Combination #2

31.43%

31.24%

38.93%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

12.16%

12.22%

16.94%

Kidney Health Evaluation for Patients with Diabetes (KED)

34.95%

33.87%

38.80%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

28.03%

30.34%

39.01%

Pharmacotherapy for Opioid Use Disorder (POD) Total

8.40%

7.75%

31.93%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

79.47%

77.77%

75.79%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

87.29%

87.45%

86.96%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

98.95%

94.83%

≤ 92.72%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

89.54%

84.67%

86.86%

Prenatal and Postpartum Care (PPC) Postpartum Care

79.56%

76.89%

80.78%

Prenatal Immunization Status (PRS) Combination Rate

21.90%

19.41%

25.81

Risk of Continued Opioid Use (COU) 31-Day Total

3.73%

8.62%

≤ 2.45%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

83.20%

82.58%

81.64%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

74.98%

92.26%

73.63%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

69.77%

67.95%

67.07%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

69.74%

88.30%

70.37%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

58.05%

54.32%

63.89%

Use of Imaging Studies for Low Back Pain (LBP)

69.44%

70.00%

75.44%

Use of Opioids at High Dosage (HDO)

2.89%

4.88%

≤ 2.19%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

1.42%

1.10%

≤ 0.87%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

80.54%

78.10%

83.21%